Merck to trial digital behavioural change programme for patients

German pharmaceutical company, Merck, will soon be trialling a digital behavioural change programme that combines remote health coaching, peer support and connected technology in a variety of countries outside the US. Merck will be working with Blue Mesa Health to provide the US digital therapeutics firm’s chronic disease prevention programme to diabetes patients. Last year,

Continue Reading

Personalised app for diabetes launched by Novo to aid management of the condition

The digital health deal between Novo Nordisk’s and Glooko produced a new diabetes management app, C4C that they hope will assist users to better manage the condition. The C4C app also includes relevant content and resources from Novo’s Cornerstones4Care personalised support programme. David Moore, senior vice president of marketing at Novo Nordisk, said: “In today’s

Continue Reading

Novo Nordisk and Glooko collaborate to develop digital health solutions for diabetes patients

Novo Nordisk and Glooko have announced that they will work together to deliver jointly-developed and branded digital health solutions for people with diabetes. The non-exclusive collaboration will combine Novo Nordisk’s deep knowledge of diabetes with Glooko’s digital platform and data expertise. Building upon Glooko’s mobile and web platforms, the companies aim to deliver personalised services

Continue Reading